[1] 马丽,赵孟君,吴海东.系统性红斑狼疮患者肿瘤坏死因子α的变化及意义.中华医学杂志,1996.76:782-784. [2] 王育新,章友康.朱世乐,等.肿瘤坏死因子的基因多态性与系统性红斑狼疮的相关性分析.中华医学杂志.1998,78:111-114 [3] 尹国华,张开明,唱文娟,等.系统性红斑狼疮患者尿中某些细胞因子的检测.中华皮肤科杂志,1998,31:39. [4] Valentijn RM,van Overhagen H,Hazevoet HM,et al.The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus.Arthritis Rheum,1985,28:904-913. [5] 张开明,刘梅青,尹兴平.等.银屑病患者血清可溶性肿瘤坏死因子受体水平的检测.中华医学杂志,1998,78:524-525 [6] Tsuji Y,Watanabe N,Okamoto T,et al.Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity.Cancer Res,1992,52:6258-6262. [7] Bonifati C,Trento E,Carducci M,et al.Soluble E-selectin and soluble tumour necrosis factor receptor(60kD)serum levels in patients with psoriasis.Dermatology,1995,190:128-132. |